<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Fubito Nakatsu</submitter><journal>The Journal of Cell Biology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-JCBD-201206095</full_dataset_link><attach_to>JCB</attach_to><legend>Imaging of Golgi complex PtdIns4P  in control MEFs using GFP-GOLPH3.</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), colocalize with the endocytic clathrin machinery component Dynamin 2 (red) in PI4KIII[alpha] KO MEFs.</legend><legend>TIRF microscopic analysis of PI4KIII[alpha] KO MEFs transfected with STIM1-mRFP before the addition of thapsigargin.</legend><legend>F-actin in control MEFs as revealed by staining with fluorescently-labeled phalloidin.</legend><legend>Confocal imaging of live HeLa cells transfected with C6S/C7S/C8S/C9S EFR3A-tdTomato.</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), does not colocalize with the endosomal marker EEA1 (red) in PI4KIII[alpha] KO MEFs.</legend><legend>TIRF microscopic analysis of control MEFs transfected with STIM1-mRFP 8 min after the addition of 1 µm thapsigargin.</legend><legend>Mislocalization of plasma membrane proteins in cells lacking PI4KIII[alpha]. PI4KIII[alpha] KO MEFs were transfected with EFR3B-GFP and imaged by confocal microscopy.</legend><legend>TIRF microscopic analysis of GFP-M1-PI4KIII[alpha] shows transient visits to the plasma membrane (1 s interval between frames).</legend><legend>TIRF microscopic analysis of GFP fluorescence in HeLa cells treated with siRNA against TTC7A/B and transfected with GFP-M1-PI4KIII[alpha].</legend><legend>Chronic depletion of plasma membrane PtdIns(4,5)P2 from HeLa cells by transfection with a membrane-anchored inositol 5-phosphatase (mRFP-IPP1-CAAX, red, see cell on right) results in diffuse intracellular fluorescence of the PtdIns(4,5)P2 probe (iRFP-PH(PLC[delta], blue), but no PtdIns(4,5)P2-positive intracellular vesicles are apparent 16 h post-transfection. Note that the myristoylated/palmitoylated plasma membrane marker L10-GFP (green) is retained at the plasma membrane.</legend><legend>Mislocalization of plasma membrane proteins in cells lacking PI4KIII[alpha]. PI4KIII[alpha] KO MEFs were transfected with M1R-YFP and imaged by confocal microscopy.</legend><legend>Immunofluorescence labeling of endogenous clathrin in control MEFs, as visualized by confocal microscopy.</legend><legend>Imaging analysis of HeLa cells double-transfected with GFP-M1-PI4KIII[alpha] (green) and EFR3B-HA (red) following anti-HA immunfluorescence labeling.</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), does not colocalize with the endosomal marker Rab5 (red) in PI4KIII[alpha] KO MEFs.</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), does not colocalize with the PtdIns3P marker 2xFYVE(Hrs) (red) in PI4KIII[alpha] KO MEFs.</legend><legend>Confocal imaging of live HeLa cells transfected with C5S/C7S/C8S EFR3B-tdTomato.</legend><legend>TIRF microscopic analysis of GFP fluorescence in HeLa cells treated with negative control siRNA and transfected with GFP-M1-PI4KIII[alpha].</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), does not colocalize with the endosomal marker Rab9 (red) in PI4KIII[alpha] KO MEFs.</legend><legend>TIRF microscopic analysis of GFP fluorescence in HeLa cells treated with siRNA against EFR3A/B and TTC7A/B and transfected with GFP-M1-PI4KIII[alpha].</legend><legend>Imaging of Golgi complex PtdIns4P in PI4KIII[alpha] KO MEFs using GFP-GOLPH3.</legend><legend>Palmitoylation of EFR3B is required for recruitment of TTC7B and PI4KIII[alpha] to the plasma membrane. Spinning-disc confocal imaging analysis of HeLa cells transfected with GFP-M1-PI4KIII[alpha] (green), TTC7B-mCherry (red), and the C5S/C7S/C8S triple mutant of EFR3B-FLAG (blue).</legend><legend>TIRF microscopic analysis of PI4KIIIa KO MEFs transfected with STIM1-mRFP 8 min after the addition of 1 µm thapsigargin.</legend><legend>Confocal imaging of live HeLa cells transfected with TTC7B-GFP.</legend><legend>TIRF microscopic analysis of control MEFs transfected with STIM1-mRFP before the addition of thapsigargin.</legend><legend>Immunofluorescence labeling of AP-2 in control MEFs.</legend><legend>Imaging of PtdIns(4,5)P2 distribution in control MEFs using RFP-PH(PLC[delta]).</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), colocalize with the endocytic clathrin machinery component epsin 1 (red) in PI4KIII[alpha] KO MEFs.</legend><legend>Immunofluorescence labeling of AP-2 in PI4KIII[alpha] KO MEFs.</legend><legend>Acute depletion of plasma membrane PtdIns(4,5)P2 using an optogenetic approach results in diffuse intracellular fluorescence of the PtdIns(4,5)P2 probe iRFP-PH(PLC[delta]) but no detectable PtdIns(4,5)P2-positive intracellular vesicles. This image is of iRFP-PH(PLC[delta]) fluorescence before light-mediated PtdIns(4,5)P2 depletion.</legend><legend>TIRF microscopic analysis of PI4KIII[alpha] KO MEFs transfected with STIM1-mRFP and GFP-M1*-PI4KIII[alpha] to rescue before the addition of thapsigargin.</legend><legend>Imaging of PtdIns(4,5)P2 distribution in PI4KIII[alpha] KO MEFs using RFP-PH(PLC[delta]).</legend><legend>Acute depletion of plasma membrane PtdIns(4,5)P2 using an optogenetic approach results in diffuse intracellular fluorescence of the PtdIns(4,5)P2 probe iRFP-PH(PLC[delta]) but no detectable PtdIns(4,5)P2-positive intracellular vesicles. This image is of iRFP-PH(PLC[delta]) fluorescence 1 min after light-mediated PtdIns(4,5)P2 depletion.</legend><legend>Localization of GFP-PH(Osh2) in PI4KIII[alpha] KO MEFs.</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), colocalize with the endocytic clathrin machinery component AP-2 (red) in PI4KIII[alpha] KO MEFs.</legend><legend>TIRF microscopic analysis of GFP fluorescence in HeLa cells treated with siRNA against EFR3A/B and transfected with GFP-M1-PI4KIII[alpha].</legend><legend>Confocal imaging of live HeLa cells transfected with wild-type EFR3A-tdTomato.</legend><legend>Immunofluorescence labeling of endogenous clathrin in PI4KIII[alpha] KO MEFs, as visualized by confocal microscopy.</legend><legend>Imaging of Golgi complex morphology in PI4KIII[alpha] KO MEFs using anti-GM130 immunofluorescence.</legend><legend>Immunofluorescence labeling of epsin 1 in control MEFs.</legend><legend>Imaging analysis of HeLa cells triple-transfected with GFP-M1-PI4KIII[alpha] (green), TTC7B-mCherry (red), and EFR3B-HA (blue). EFR3B-HA immunofluorescence was performed with an anti-HA antibody followed by an Alexa Fluor 647-conjugated anti-rat secondary antibody.</legend><legend>TIRF microscopic analysis of PI4KIII[alpha] KO MEFs transfected with STIM1-mRFP and GFP-M1-PI4KIII[alpha] to rescue before the addition of thapsigargin.</legend><legend>Acute depletion of plasma membrane PtdIns(4,5)P2 using an optogenetic approach results in diffuse intracellular fluorescence of the PtdIns(4,5)P2 probe iRFP-PH(PLC[delta]) but no detectable PtdIns(4,5)P2-positive intracellular vesicles. This image is of iRFP-PH(PLC[delta]) fluorescence 30 min after light-mediated PtdIns(4,5)P2 depletion.</legend><legend>Confocal imaging of HeLa cells transfected with GFP-M1-PI4KIII[alpha].</legend><legend>TIRF microscopic analysis of GFP-M1*-PI4KIII[alpha] shows no transient visits to the plasma membrane (1 s interval between frames).</legend><legend>Colocalization of GFP-PIPK1[gamma] (green) and RFP-PH(PLC[delta]) (red) on intracellular sites in PI4KIII[alpha] KO MEFs as assessed by confocal microscopy.</legend><legend>Acute depletion of plasma membrane PtdIns(4,5)P2 using an optogenetic approach results in diffuse intracellular fluorescence of the PtdIns(4,5)P2 probe iRFP-PH(PLC[delta]) but no detectable PtdIns(4,5)P2-positive intracellular vesicles. This image is of iRFP-PH(PLC[delta]) fluorescence 60 min after light-mediated PtdIns(4,5)P2 depletion.</legend><legend>Confocal imaging of live HeLa cells transfected with EFR3B-tdTomato.</legend><legend>TIRF microscopic analysis of PI4KIII[alpha] KO MEFs transfected with STIM1-mRFP and GFP-M1*-PI4KIII[alpha] to rescue 8 min after the addition of 1 µm thapsigargin.</legend><legend>Imaging analysis of HeLa cells double-transfected with TTC7B-mCherry (red) and EFR3B-HA (green) following anti-HA immunfluorescence labeling.</legend><legend>Imaging of Golgi complex morphology in control MEFs using anti-GM130 immunofluorescence.</legend><legend>TIRF microscopic analysis of GFP fluorescence in HeLa cells treated with negative control siRNA and transfected with GFP-M1*-PI4KIII[alpha].</legend><legend>Localization of GFP-PH(Osh2) in control MEFs.</legend><legend>Immunofluorescence labeling of epsin 1 in PI4KIII[alpha] KO MEFs.</legend><legend>Mislocalization of plasma membrane proteins in cells lacking PI4KIII[alpha]. PI4KIII[alpha] KO MEFs were transfected with L10-GFP and imaged by confocal microscopy.</legend><legend>TIRF microscopic analysis of PI4KIIIa KO MEFs transfected with STIM1-mRFP and GFP-M1-PI4KIIIa to rescue 8 min after the addition of 1 µm thapsigargin.</legend><legend>F-actin in PI4KIII[alpha] KO MEFs as revealed by staining with fluorescently-labeled phalloidin.</legend><legend>Palmitoylation of EFR3B is required for recruitment of TTC7B and PI4KIII[alpha] to the plasma membrane. Spinning-disc confocal imaging analysis of HeLa cells transfected with GFP-M1-PI4KIII[alpha] (green), TTC7B-mCherry (red), and wild-type EFR3B-FLAG (blue).</legend><legend>PtdIns(4,5)P2-positive intracellular vesicles, visualized with PH(PLC[delta]) (green), do not colocalize with the Golgi PtdIns4P marker PH(OSBP) (red) in PI4KIII[alpha] KO MEFs.</legend><legend>Confocal imaging of HeLa cells transfected with GFP-M1*-PI4KIII[alpha].</legend><repository>bioimages</repository><figure_sub>Image 139031 (Figure 7 - G)</figure_sub><figure_sub>Figure 8 - A</figure_sub><figure_sub>Figure 8 - B</figure_sub><figure_sub>Figure 3 - None</figure_sub><figure_sub>Image 139021 (Figure 6 - I)</figure_sub><figure_sub>Image 139005 (Figure 4 - C)</figure_sub><figure_sub>Image 139013 (Figure 6 - A and B)</figure_sub><figure_sub>Image 139280 (Figure 7 - C)</figure_sub><figure_sub>Supplemental Figure 2 - A</figure_sub><figure_sub>Supplemental Figure 2 - B</figure_sub><figure_sub>Image 139398 (Figure 1 - E)</figure_sub><figure_sub>Image 139007 (Figure 5 - G)</figure_sub><figure_sub>Image 138986 (Figure 2 - C)</figure_sub><figure_sub>Image 139056 (Supplemental Figure 5 - A)</figure_sub><figure_sub>Image 139291 (Supplemental Figure 2 - B)</figure_sub><figure_sub>Figure 1 - A</figure_sub><figure_sub>Image 139284 (Figure 8 - A)</figure_sub><figure_sub>Figure 1 - E</figure_sub><figure_sub>Image 139011 (Figure 5 - D)</figure_sub><figure_sub>Image 139285 (Figure 8 - A)</figure_sub><figure_sub>Figure 6 - A and B</figure_sub><figure_sub>Image 139023 (Figure 6 - J)</figure_sub><figure_sub>Image 139027 (Figure 7 - A)</figure_sub><figure_sub>Image 139001 (Figure 3 - None)</figure_sub><figure_sub>Image 138999 (Figure 3 - None)</figure_sub><figure_sub>Image 139032 (Figure 7 - G)</figure_sub><figure_sub>Image 139052 (Figure 8 - B)</figure_sub><figure_sub>Image 139010 (Figure 5 - D)</figure_sub><figure_sub>Image 139003 (Figure 4 - C)</figure_sub><figure_sub>Image 138964 (Figure 1 - A)</figure_sub><figure_sub>Figure 6 - G and H</figure_sub><figure_sub>Figure 5 - F</figure_sub><figure_sub>Image 139008 (Figure 5 - F)</figure_sub><figure_sub>Figure 5 - G</figure_sub><figure_sub>Image 139054 (Figure 8 - B)</figure_sub><figure_sub>Image 139399 (Figure 1 - E)</figure_sub><figure_sub>Figure 5 - D</figure_sub><figure_sub>Image 139288 (Figure 8 - A)</figure_sub><figure_sub>Figure 5</figure_sub><figure_sub>Figure 4</figure_sub><figure_sub>Figure 7</figure_sub><figure_sub>Image 139293 (Figure 2 - E)</figure_sub><figure_sub>Figure 6</figure_sub><figure_sub>Figure 8</figure_sub><figure_sub>Figure 1</figure_sub><figure_sub>Supplemental Figure 5 - A</figure_sub><figure_sub>Figure 3</figure_sub><figure_sub>Figure 2</figure_sub><figure_sub>Supplemental Figure 5</figure_sub><figure_sub>Supplemental Figure 2</figure_sub><figure_sub>Figure 7 - A</figure_sub><figure_sub>Figure 7 - C</figure_sub><figure_sub>Image 139286 (Figure 8 - A)</figure_sub><figure_sub>Figure 7 - G</figure_sub><figure_sub>Figure 7 - H</figure_sub><figure_sub>Figure 6 - C and D</figure_sub><figure_sub>Image 139025 (Figure 6 - K)</figure_sub><figure_sub>Image 139009 (Figure 5 - F)</figure_sub><figure_sub>Image 139283 (Figure 8 - A)</figure_sub><figure_sub>Image 138987 (Figure 2 - C)</figure_sub><figure_sub>Image 138998 (Figure 3 - None)</figure_sub><figure_sub>Image 139290 (Supplemental Figure 2 - A)</figure_sub><figure_sub>Figure 2 - E</figure_sub><figure_sub>Figure 2 - F</figure_sub><figure_sub>Image 139006 (Figure 5 - G)</figure_sub><figure_sub>Image 139030 (Figure 7 - G)</figure_sub><figure_sub>Figure 2 - C</figure_sub><figure_sub>Figure 2 - D</figure_sub><figure_sub>Image 139014 (Figure 6 - C and D)</figure_sub><figure_sub>Image 139055 (Supplemental Figure 5 - A)</figure_sub><figure_sub>Image 139282 (Figure 8 - A)</figure_sub><figure_sub>Image 139017 (Figure 6 - E and F)</figure_sub><figure_sub>Figure 6 - E and F</figure_sub><figure_sub>Image 139019 (Figure 6 - G and H)</figure_sub><figure_sub>Image 139002 (Figure 3 - None)</figure_sub><figure_sub>Figure 4 - C</figure_sub><figure_sub>Image 139287 (Figure 8 - A)</figure_sub><figure_sub>Figure 6 - K</figure_sub><figure_sub>Image 139018 (Figure 6 - G and H)</figure_sub><figure_sub>Image 139033 (Figure 7 - G)</figure_sub><figure_sub>Image 139015 (Figure 6 - C and D)</figure_sub><figure_sub>Figure 6 - I</figure_sub><figure_sub>Image 139294 (Figure 2 - F)</figure_sub><figure_sub>Figure 6 - J</figure_sub><figure_sub>Image 139012 (Figure 6 - A and B)</figure_sub><figure_sub>Image 139053 (Figure 8 - B)</figure_sub><figure_sub>Image 139024 (Figure 6 - K)</figure_sub><figure_sub>Image 138965 (Figure 1 - A)</figure_sub><figure_sub>Image 139020 (Figure 6 - I)</figure_sub><figure_sub>Image 139016 (Figure 6 - E and F)</figure_sub><figure_sub>Image 139000 (Figure 3 - None)</figure_sub><figure_sub>Image 139022 (Figure 6 - J)</figure_sub><figure_sub>Image 139026 (Figure 7 - A)</figure_sub><figure_sub>Image 139292 (Figure 2 - D)</figure_sub><figure_sub>Image 139004 (Figure 4 - C)</figure_sub><figure_sub>Image 139289 (Figure 8 - A)</figure_sub><figure_sub>Image 139281 (Figure 7 - H)</figure_sub><pubmed_authors>Lukas B. Tanner</pubmed_authors><pubmed_authors>Mingming Hao</pubmed_authors><pubmed_authors>Markus R. Wenk</pubmed_authors><pubmed_authors>Fubito Nakatsu</pubmed_authors><pubmed_authors>Guanghou Shui</pubmed_authors><pubmed_authors>Michelle Pirruccello</pubmed_authors><pubmed_authors>Sang Yoon Lee</pubmed_authors><pubmed_authors>Nicholas T. Ingolia</pubmed_authors><pubmed_authors>Jeeyun Chung</pubmed_authors><pubmed_authors>Pietro De Camilli</pubmed_authors><pubmed_authors>Jeremy M. Baskin</pubmed_authors></additional><is_claimable>false</is_claimable><name>PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity</name><description/><dates><release>2012-12-10T11:23:39Z</release><modification>2018-11-29T11:23:39Z</modification><creation>2018-11-29T11:23:39Z</creation></dates><accession>S-JCBD-201206095</accession><cross_references><doi>10.1083/jcb.201206095</doi></cross_references></HashMap>